The difference in the median survival between the two therapy groups did not reach statistical significance ( p = 0.45 by the log-rank test).
← all excerpts
Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice.
1
0.4500
0.4500